Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05742750
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-24
First Post:
2023-02-15
Brief Title:
A Phase IbII Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Organization Data
Organization:
Sun Yat-sen University
Class:
OTHER
Study ID:
22-OBU-GD-EC-II-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sun Yat-sen University
Lead Sponsor Class:
OTHER
Responsible Party:
Dong sheng Zhang
Responsible Party Title:
Chief physicianprofessor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sun Yat-sen University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Jiangsu Hengrui Pharmaceutical Co Ltd | INDUSTRY |